메뉴 건너뛰기




Volumn 151, Issue 10, 2009, Pages 750-752

Evidence-based breast cancer prevention: The importance of individual risk

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; TAMOXIFEN;

EID: 72049133423     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-151-10-200911170-00012     Document Type: Editorial
Times cited : (39)

References (30)
  • 2
    • 19944430591 scopus 로고    scopus 로고
    • Association between mammography timing and measures of screening performance in the United States
    • PMID: 15670994
    • Yankaskas BC, Taplin SH, Ichikawa L, Geller BM, Rosenberg RD, Carney PA, et al. Association between mammography timing and measures of screening performance in the United States. Radiology. 2005;234:363-373 [PMID: 15670994]
    • (2005) Radiology , vol.234 , pp. 363-373
    • Yankaskas, B.C.1    Taplin, S.H.2    Ichikawa, L.3    Geller, B.M.4    Rosenberg, R.D.5    Carney, P.A.6
  • 3
    • 34548573004 scopus 로고    scopus 로고
    • Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population
    • National Cancer Institute-Sponsored Breast Cancer Surveillance Consortium. PMID: 17698950
    • Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA; National Cancer Institute-Sponsored Breast Cancer Surveillance Consortium. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007;99:1335-1339 [PMID: 17698950]
    • (2007) J Natl Cancer Inst , vol.99 , pp. 1335-1339
    • Kerlikowske, K.1    Miglioretti, D.L.2    Buist, D.S.3    Walker, R.4    Carney, P.A.5
  • 5
    • 33750985352 scopus 로고    scopus 로고
    • Prescription of tamoxifen for breast cancer prevention by primary care physicians
    • PMID: 17101945
    • Armstrong K, Quistberg DA, Micco E, Domchek S, Guerra C. Prescription of tamoxifen for breast cancer prevention by primary care physicians. Arch Intern Med. 2006;166:2260-2265 [PMID: 17101945]
    • (2006) Arch Intern Med , vol.166 , pp. 2260-2265
    • Armstrong, K.1    Quistberg, D.A.2    Micco, E.3    Domchek, S.4    Guerra, C.5
  • 6
    • 72049100691 scopus 로고    scopus 로고
    • Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
    • U.S. Preventive Services Task Force
    • U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151:716-726
    • (2009) Ann Intern Med , vol.151 , pp. 716-726
  • 7
    • 72049090936 scopus 로고    scopus 로고
    • Screening for breast cancer: An update for the U.S. Preventive Services Task Force
    • Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727-737
    • (2009) Ann Intern Med , vol.151 , pp. 727-737
    • Nelson, H.D.1    Tyne, K.2    Naik, A.3    Bougatsos, C.4    Chan, B.K.5    Humphrey, L.6
  • 8
    • 72049091776 scopus 로고    scopus 로고
    • Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms
    • Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151: 738-747
    • (2009) Ann Intern Med , vol.151 , pp. 738-747
    • Mandelblatt, J.S.1    Cronin, K.A.2    Bailey, S.3    Berry, D.A.4    De Koning, H.J.5    Draisma, G.6
  • 9
    • 72049084001 scopus 로고    scopus 로고
    • Systematic review: Comparative effectiveness of medications to reduce risk for primary breast cancer
    • Nelson HD, Fu R, Griffin JC, Nygren PN, Smith ME, Humphrey L. Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med. 2009;151:703-715
    • (2009) Ann Intern Med , vol.151 , pp. 703-715
    • Nelson, H.D.1    Fu, R.2    Griffin, J.C.3    Nygren, P.N.4    Smith, M.E.5    Humphrey, L.6
  • 11
    • 33845216421 scopus 로고    scopus 로고
    • Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: A randomised controlled trial
    • Trial Management Group. PMID: 17161727
    • Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368:2053-2060 [PMID: 17161727]
    • (2006) Lancet , vol.368 , pp. 2053-2060
    • Moss, S.M.1    Cuckle, H.2    Evans, A.3    Johns, L.4    Waller, M.5    Bobrow, L.6
  • 12
    • 0037015185 scopus 로고    scopus 로고
    • Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force
    • PMID: 12204020
    • Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347-360 [PMID: 12204020]
    • (2002) Ann Intern Med , vol.137 , pp. 347-360
    • Humphrey, L.L.1    Helfand, M.2    Chan, B.K.3    Woolf, S.H.4
  • 14
    • 0034610318 scopus 로고    scopus 로고
    • Performance of screening mammography among women with and without a first-degree relative with breast cancer
    • PMID: 11103055
    • Kerlikowske K, Carney PA, Geller B, Mandelson MT, Taplin SH, Malvin K, et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med. 2000;133:855-863 [PMID: 11103055]
    • (2000) Ann Intern Med , vol.133 , pp. 855-863
    • Kerlikowske, K.1    Carney, P.A.2    Geller, B.3    Mandelson, M.T.4    Taplin, S.H.5    Malvin, K.6
  • 15
    • 0028817211 scopus 로고
    • Efficacy of screening mammography. A meta-analysis
    • PMID: 7799496
    • Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273:149-154 [PMID: 7799496]
    • (1995) JAMA , vol.273 , pp. 149-154
    • Kerlikowske, K.1    Grady, D.2    Rubin, S.M.3    Sandrock, C.4    Ernster, V.L.5
  • 16
    • 16244416817 scopus 로고    scopus 로고
    • Comparison of 1- and 2-year screening intervals for women undergoing screening mammography
    • PMID: 15714210
    • Wai ES, D'yachkova Y, Olivotto IA, Tyldesley S, Phillips N, Warren LJ, et al. Comparison of 1- and 2-year screening intervals for women undergoing screening mammography. Br J Cancer. 2005;92:961-966 [PMID: 15714210]
    • (2005) Br J Cancer , vol.92 , pp. 961-966
    • Wai, E.S.1    D'Yachkova, Y.2    Olivotto, I.A.3    Tyldesley, S.4    Phillips, N.5    Warren, L.J.6
  • 18
    • 0030686414 scopus 로고    scopus 로고
    • Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age
    • PMID: 9412300
    • Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med. 1997;127:955-965 [PMID: 9412300]
    • (1997) Ann Intern Med , vol.127 , pp. 955-965
    • Salzmann, P.1    Kerlikowske, K.2    Phillips, K.3
  • 19
    • 39649114334 scopus 로고    scopus 로고
    • Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer
    • PMID: 18270335
    • Chapman JA, Meng D, Shepherd L, Parulekar W, Ingle JN, Muss HB, et al. Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst. 2008;100:252-260 [PMID: 18270335]
    • (2008) J Natl Cancer Inst , vol.100 , pp. 252-260
    • Chapman, J.A.1    Meng, D.2    Shepherd, L.3    Parulekar, W.4    Ingle, J.N.5    Muss, H.B.6
  • 20
    • 0033536996 scopus 로고    scopus 로고
    • Continuing screening mammography in women aged 70 to 79 years: Impact on life expectancy and cost-effectiveness
    • PMID: 10591338
    • Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA. 1999;282:2156-2163 [PMID: 10591338]
    • (1999) JAMA , vol.282 , pp. 2156-2163
    • Kerlikowske, K.1    Salzmann, P.2    Phillips, K.A.3    Cauley, J.A.4    Cummings, S.R.5
  • 21
    • 0035816019 scopus 로고    scopus 로고
    • Cancer screening in elderly patients: A framework for individualized decision making
    • PMID: 11386931
    • Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285:2750-2756 [PMID: 11386931]
    • (2001) JAMA , vol.285 , pp. 2750-2756
    • Walter, L.C.1    Covinsky, K.E.2
  • 22
    • 64949188644 scopus 로고    scopus 로고
    • Prevention of breast cancer in postmenopausal women: Approaches to estimating and reducing risk
    • PMID: 19276457
    • Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101:384-398 [PMID: 19276457]
    • (2009) J Natl Cancer Inst , vol.101 , pp. 384-398
    • Cummings, S.R.1    Tice, J.A.2    Bauer, S.3    Browner, W.S.4    Cuzick, J.5    Ziv, E.6
  • 23
    • 33747886042 scopus 로고    scopus 로고
    • Chemoprevention: Drug pricing and mortality: The case of tamoxifen
    • PMID: 16865680
    • Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch S, et al. Chemoprevention: drug pricing and mortality: the case of tamoxifen. Cancer. 2006;107:950-958 [PMID: 16865680]
    • (2006) Cancer , vol.107 , pp. 950-958
    • Melnikow, J.1    Kuenneth, C.2    Helms, L.J.3    Barnato, A.4    Kuppermann, M.5    Birch, S.6
  • 24
    • 0036138716 scopus 로고    scopus 로고
    • Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: A cost-effectiveness analysis
    • PMID: 11773148
    • Hershman D, Sundararajan V, Jacobson JS, Heitjan DF, Neugut AI, Grann VR. Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. J Clin Oncol. 2002;20:9-16. [PMID: 11773148]
    • (2002) J Clin Oncol , vol.20 , pp. 9-16
    • Hershman, D.1    Sundararajan, V.2    Jacobson, J.S.3    Heitjan, D.F.4    Neugut, A.I.5    Grann, V.R.6
  • 25
    • 50949088189 scopus 로고    scopus 로고
    • Tamoxifen for breast cancer risk reduction: Impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis
    • PMID: 18725849
    • Melnikow J, Birch S, Slee C, McCarthy TJ, Helms LJ, Kuppermann M. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis. Med Care. 2008;46:946-953 [PMID: 18725849]
    • (2008) Med Care , vol.46 , pp. 946-953
    • Melnikow, J.1    Birch, S.2    Slee, C.3    McCarthy, T.J.4    Helms, L.J.5    Kuppermann, M.6
  • 26
    • 0035819891 scopus 로고    scopus 로고
    • Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention
    • PMID: 11238697
    • Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93:358-366 [PMID: 11238697]
    • (2001) J Natl Cancer Inst , vol.93 , pp. 358-366
    • Rockhill, B.1    Spiegelman, D.2    Byrne, C.3    Hunter, D.J.4    Colditz, G.A.5
  • 27
    • 34247254947 scopus 로고    scopus 로고
    • Screening mammography for women 40 to 49 years of age: A clinical practice guideline from the American College of Physicians
    • Clinical Efficacy Assessment Subcommittee of the American College of Physicians. PMID: 17404353
    • Qaseem A, Snow V, Sherif K, Aronson M, Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;146: 511-515 [PMID: 17404353]
    • (2007) Ann Intern Med , vol.146 , pp. 511-515
    • Qaseem, A.1    Snow, V.2    Sherif, K.3    Aronson, M.4    Weiss, K.B.5    Owens, D.K.6
  • 28
    • 41049090799 scopus 로고    scopus 로고
    • Using clinical factors and mammographic breast density to estimate breast cancer risk: Development and validation of a new predictive model
    • PMID: 18316752
    • Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148:337-347 [PMID: 18316752]
    • (2008) Ann Intern Med , vol.148 , pp. 337-347
    • Tice, J.A.1    Cummings, S.R.2    Smith-Bindman, R.3    Ichikawa, L.4    Barlow, W.E.5    Kerlikowske, K.6
  • 29
    • 33748679482 scopus 로고    scopus 로고
    • Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density
    • PMID: 16954474
    • Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst. 2006;98:1215-1226 [PMID: 16954474]
    • (2006) J Natl Cancer Inst , vol.98 , pp. 1215-1226
    • Chen, J.1    Pee, D.2    Ayyagari, R.3    Graubard, B.4    Schairer, C.5    Byrne, C.6
  • 30
    • 0030947869 scopus 로고    scopus 로고
    • Contentious screening decisions: Does the choice matter?
    • Editorial. PMID: 9110913
    • Pauker SG, Kassirer JP. Contentious screening decisions: does the choice matter? [Editorial]. N Engl J Med. 1997;336:1243-1244 [PMID: 9110913]
    • (1997) N Engl J Med , vol.336 , pp. 1243-1244
    • Pauker, S.G.1    Kassirer, J.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.